HOME >> BIOLOGY >> NEWS
Fe-TAML(R) activators developed at Carnegie Mellon help cleanup paper and wood pulp manufacturing

NEW YORK-- Potent, environmentally friendly catalysts called Fe-TAML activators, developed by scientists at Carnegie Mellon University, can destroy colored pollutants and toxic compounds resulting from paper and wood pulp processing.

The results of extensive field trials conducted by Carnegie Mellon University, Forest Research of New Zealand and the University of Auckland are being presented by Dr. L. James Wright of the University of Auckland on Wed., Sept. 10, in New York City at the 226th annual meeting of the American Chemical Society (paper 177, "Activation of hydrogen peroxide with a TAML catalyst for wastewater remediation in the pulp and paper industry," Industrial & Engineering Chemistry Division).

"Right now, we can use Fe-TAMLs with hydrogen peroxide to clean up the unsightly color from chlorine-based bleaching processes used by mills to make paper and the chlorinated byproducts of those processes, which are considered a potential health hazard," said Terry Collins, the Thomas Lord Professor of Chemistry at Carnegie Mellon and the chief researcher on the Fe-TAML project. Collins describes the results of the decolorization as going from 'coffee' to 'lemonade.'

Fe-TAMLs (TAML stands for tetra-amido macrocyclic ligand) are synthetic catalysts made with elements found in nature.

While the current study shows that the Fe-TAML activators are extremely promising in cleanup efforts, their real promise may be in replacing altogether chlorine-based bleaching processes currently in place. If accomplished, this substitution would virtually avert the formation of chlorinated byproducts altogether and greatly reduce or eliminate color production associated with paper processing, according to Collins.

The paper and wood pulp manufacturing process produces approximately 100 million tons of bleached pulp each year for use in the manufacture of a variety of cellulose-based products including white paper. In standard mill paper
'"/>

Contact: Lauren Ward
wardle@andrew.cmu.edu
412-268-7761
Carnegie Mellon University
10-Sep-2003


Page: 1 2 3

Related biology news :

1. Fe-TAML(R) activators developed at Carnegie Mellon remove recalcitrant sulfur from automotive fuels
2. Fe-TAML(R) activators developed at Carnegie Mellon decontaminate anthrax simulant
3. Fe-TAML(R) activators developed at Carnegie Mellon break down toxic pesticides
4. Fe-TAML(R) activators developed at Carnegie Mellon decolorize textile mill wastewater
5. Computer database being developed at Temple will allow for better inventory of chemicals
6. New software developed at Rensselaer predicts promising ingredients for new drugs
7. New imaging technique developed to identify breast cancer
8. Portable kidney dialysis machine developed
9. New method of identifying and isolating stem cells developed
10. Study calls for cheaper antitoxins for plant poisoning in less-developed countries
11. Drug developed for rare disease may help millions more as treatment for cancer, autoimmune diseases

Post Your Comments:
(Date:4/2/2015)... , April 2, 2015 ... DERMALOG by far outperforms the strongest competitors, showing ... high accuracy, the system is capable of a ... speed proves up to be ten times faster ... its runner-up performance.      (Photo: ...
(Date:4/1/2015)... OXFORD, Conn. , Apr. 1, 2015  NXT-ID, ... a biometric authentication company focused on the growing mobile ... number of Wocket smart wallets is underway to early ... early access group includes usage at retail outlets including ... CVS Pharmacy. Users report Wocket was accepted at all ...
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... of the "Global Gesture Recognition Market in Automotive ... The analysts forecast the Global Gesture Recognition market in ... over the period 2013-2018. Gesture recognition is ... to different gestures of an individual. Gesture recognition technology ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
(Date:4/23/2015)... April 23, 2015 Proove ... Personalized Medicine, is excited to announce the launch ... . This profile assesses 62 genetic variations to ... information for commonly prescribed non-opioid pain medications, namely ... Neurontin), alprazolam (brand name Xanax) and acetaminophen (brand ...
(Date:4/23/2015)... ReliantHeart's HeartAssist5® Ventricular Assist Device (VAD) precisely measure ... in real time, and this data is uploaded to ... Machine to Machine (M2M) communications for the Internet of ... can be monitored by a patient’s clinician 24/7, ... a minimum threshold, the patient can be notified immediately. ...
(Date:4/22/2015)... /PRNewswire/ - BioAmber Inc. (NYSE and EURONEXT Paris:BIOA) today announced that it will ... Thursday, May 7, 2015 after the close of the ... call for 4.30 pm ET (1.30 pm PT) to ... the conference call will be webcast over the internet ... news media and the general public. To access the ...
(Date:4/22/2015)... Va. , April 22, 2015 ... TowerView Health was the winner of the 9th annual ... Fifteen startup companies were selected to deliver live ... industry leaders, as part of HIMSS15 held last week ... more than 43,000 health IT professionals and 1,200 exhibiting ...
Breaking Biology Technology:Proove Biosciences Launches World’s First Test to Predict Responders to Commonly Prescribed Non-Opioid Pain Medications 2Proove Biosciences Launches World’s First Test to Predict Responders to Commonly Prescribed Non-Opioid Pain Medications 3BioAmber Announces Webcast of Fiscal First Quarter 2015 Financial Results 2TowerView Health Named Venture+ Forum Pitch Competition Winner At HIMSS15 2TowerView Health Named Venture+ Forum Pitch Competition Winner At HIMSS15 3
Cached News: